Hudson Bay Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Hudson Bay Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$5.17M	–	1025
2022 Q4	$5.17M	Hold	10,000	–	–	0.05%	338
2022 Q3	$5.08M	Hold	10,000	–	–	0.05%	400
2022 Q2	$5M	Hold	10,000	–	–	0.04%	424
2022 Q1	$5M	Buy	+10,000	New	+$4.97M	0.07%	363

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hudson Bay Capital Management's TVGN Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 10,000 shares — an estimated $5.17M sold.

Hudson Bay Capital Management first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $5.17M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Hudson Bay Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 10,000 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $5.17M.
Hudson Bay Capital Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Hudson Bay Capital Management's Tevogen Inc. Common Stock position peaked at $5.17M in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.